Abstract:Background Polygenic risk scores (PRS) have ushered in a new era in genetic epidemiology, offering insights into individual predispositions to a wide range of diseases. However, despite recent marked enhancements in their predictive power, there are still challenges that need to be overcome before PRS-based models can be broadly applied in the clinic, including sufficient accuracy, easy interpretability and portability across diverse populations. Methods Leveraging trans-ancestry genome-wide association study (GWAS) meta-analysis, we generated novel, diverse summary statistics for 30 medically-related traits which were used to benchmark the performance of six existing PRS algorithms using UK biobank. Observing that SBayesRC had the best overall performance but recognizing strengths in each method, we developed an ensemble PRS model using logistic regression to combine outputs from top-performing algorithms. This ensemble model was validated on the diverse eMERGE and PAGE MEC cohorts, and the performance was compared against current state-of-the-art PRS models. To enhance predictive accuracy for clinical application, we incorporated easily-accessible clinical characteristics such as age, gender, ancestry and risk factors, creating disease prediction models intended as prospective diagnostic tests, with easily interpretable positive or negative outcomes. Results Predictive performance of PRS models improved with trans-ancestry GWAS meta-analysis and was further enhanced by the ensemble model, which surpassed state-of-art PRS models. When applied to external cohorts, performance drops were minimal, indicating good calibration. After adding clinical characteristics, 12 out of 30 models surpassed 80% AUC. Further, 25 traits exceeded the diagnostic odds ratio (DOR) of 5 and 19 traits exceeded DOR of 10 for all ancestry groups, indicating high predictive value. The highest DOR in a population with a sufficient number of cases was 66.2 for Alzheimer's disease in Europeans. Our PRS model for coronary artery disease identified 55-80 times more true coronary events than rare pathogenic variant models, reinforcing its clinical potential. The polygenic component modulated the effect of high-risk rare variants, stressing the need to consider all genetic components in clinical settings. Conclusions Newly developed PRS-based disease prediction models have sufficient accuracy and portability to warrant consideration of being used in the clinic.

Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer

Genomic Prediction of Complex Disease Risk

Machine Learning Prediction of Biomarkers from SNPs and of Disease Risk from Biomarkers in the UK Biobank

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations

Identifying and characterizing disease subpopulations that most benefit from polygenic risk scores

A comprehensive investigation of statistical and machine learning approaches for predicting complex human diseases on genomic variants

A unified framework for estimating country-specific cumulative incidence for 18 diseases stratified by polygenic risk

Optimization of Multi-Ancestry Polygenic Risk Score Disease Prediction Models

A Deep Learning-based Genome-wide Polygenic Risk Score for Common Diseases Identifies Individuals with Risk

Utility of polygenic scores across diverse diseases in a hospital cohort for predictive modeling

Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers

Comparisons of Polyexposure, Polygenic, and Clinical Risk Scores in Risk Prediction of Type 2 Diabetes

Genetic risk prediction in complex disease

Polygenic risk scores for the prediction of cardiometabolic disease

An Improved Genome-Wide Polygenic Score Model for Predicting the Risk of Type 2 Diabetes

Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score

Integrated clinical risk prediction of type 2 diabetes with a multifactorial polygenic risk score

Development of a Polygenic Risk Score to Improve Detection of Peripheral Artery Disease

Improving on polygenic scores across complex traits using select and shrink with summary statistics (S4) and LDpred2

Machine learning models for predicting blood pressure phenotypes by combining multiple polygenic risk scores